Atrys Health receives support from the European Union and Eureka, through its Eurostars-2 Program, for the cancer research project TheraYAP
November 25, 2016
• Atrys Health receives a grant of more than € 0.6M for the implementation of the TheraYAP project
• TheraYAP confirms the leadership of Atrys Health in the development of specialized diagnostic tests or "companion diagnostics"
Madrid, November 24th, 2016. - Atrys Health, a company specialized in diagnostic services and advanced cancer treatments, has received a € 632m grant for the development of the international cancer research project TheraYAP. This grant is co-financed by the Center for Industrial Technological Development and by the European Union through the Horizon 2020 Research and Innovation Framework Program.